Giant left anterior descending artery aneurysm in a patient with active systemic lupus erythematosus: a case report
Zipeng Yao1, Yanhong Long1, Zheng Zong2
1Department of Cardiology, The First People's Hospital of Tianmen, Tianmen, 431700, China.
Insights
Systemic lupus erythematosus (SLE) patients require screening for coronary artery aneurysms (CAAs). Early detection and treatment with anticoagulation and antiplatelet therapy are crucial for managing this rare but serious condition.
Area of Science:
- Cardiology
- Rheumatology
- Vascular Medicine
Background:
- Coronary artery aneurysms (CAAs) are rare but can grow to giant sizes (>8 mm).
- Systemic lupus erythematosus (SLE) is associated with autoantibody- and immune complex-mediated atherosclerosis, a common cause of CAAs in these patients.
Observation:
- A 53-year-old female SLE patient presented with chest pain.
- Coronary angiography revealed a giant aneurysm in the left anterior descending artery (LAD) and occlusion in the left circumflex artery (LCX).
- Risk factors included abnormal pulmonary enzymes, dyslipidemia, and nephritis.
Findings:
- Anticoagulation and antiplatelet therapy were initiated to prevent thromboembolism.
- Stent implantation in the LCX restored TIMI grade III flow.
- The patient's chest pain resolved, and she remained healthy during 6-month follow-up.
Implications:
- This case highlights the importance of screening SLE patients for CAAs.
- Prompt diagnosis and management, including anticoagulation and antiplatelet therapy, are essential for favorable outcomes in CAA patients with SLE.
Background:
Although not common, coronary artery aneurysms (CAAs) can develop to over 8 mm in diameter to become giant CAAs. In the context of systemic lupus erythematosus (SLE), autoantibody- and immune complex-mediated atherosclerosis is believed to be the most prevalent cause of aneurysm.
Case Presentation:
We report the case of a 53-year-old female SLE patient who presented to our hospital with radiating chest pain. Coronary angiography revealed a giant aneurysm in the middle segment of the left anterior descending artery (LAD) and distal subtotal occlusion in the left circumflex artery (LCX). Laboratory testing also identified risk factors such as an abnormal pulmonary enzyme profile, dyslipidemia, and nephritis parameters.To prevent thromboembolism, anticoagulation and antiplatelet therapy were administered. In addition, one stent was implanted at the distal end of the LCX and repeated coronary angiography verified restoration of TIMI grade III flow.The patient was discharged with resolved chest pain. During 6 months of follow-up, the patient is in good health.
Conclusions:
Our case study, together with 16 recent comparable reports, emphasizes the need for coronary aneurysm screening in SLE patients. It is necessary that thromboembolism, anticoagulation and antiplatelet therapy were administered for CAA.
Related Concept Videos
The Aorta
The average diameter of the aorta is approximately 2-3 cm, but the size can vary depending on the section of the aorta and the individual's age, sex, and body size. The aorta is...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aortic Regurgitation III: Medical Management
Aneurysm I: Introduction
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Aneurysm III: Interprofessional Care


